The TH Antibody, FITC conjugated, is a rabbit-derived polyclonal immunoglobulin G (IgG) antibody conjugated to FITC via primary amine groups (e.g., lysine residues) . Key characteristics include:
This antibody is widely used for detecting TH in:
IHC-P (Paraffin): Localizes TH in fixed tissue sections (e.g., brain, adrenal glands) .
IHC-F (Frozen) and ICC: Visualizes TH in fresh or cultured cells .
| Method | Dilution Range |
|---|---|
| WB | 1:300–1:5000 |
| IF (IHC-P, IHC-F, ICC) | 1:50–1:200 |
FITC conjugation requires precise optimization to balance brightness and specificity:
| Parameter | Recommendation |
|---|---|
| pH | 9.5 |
| Temperature | Room temperature (20–25°C) |
| Reaction Time | 30–60 minutes for maximal F/P ratio |
| Protein Concentration | 25 mg/ml (initial) |
Over-conjugation: High FITC-to-antibody ratios (>6) reduce binding affinity and increase background noise .
Sodium Azide: Must be removed prior to conjugation to prevent FITC inactivation .
Studies show an inverse correlation between FITC-labeling density and antibody affinity :
| FITC Labeling Index | Binding Affinity | Sensitivity | Background Risk |
|---|---|---|---|
| Low (3–4 FITC/Ab) | High | Moderate | Low |
| High (6+ FITC/Ab) | Reduced | High | Increased |
Higher FITC labeling improves signal intensity but may compromise specificity, necessitating titration for optimal results .
DEAE Sephadex chromatography separates optimally labeled antibodies from under- or over-labeled fractions .
The table below highlights examples of FITC-conjugated antibodies and their applications:
Tyrosine hydroxylase catalyzes the rate-limiting step in dopamine, norepinephrine, and epinephrine biosynthesis, making it a critical marker for dopaminergic neurons and adrenal chromaffin cells . FITC conjugation enables fluorescence-based detection in techniques like immunofluorescence (IF) and immunohistochemistry (IHC), providing spatial resolution of TH expression in tissue sections or cultured neurons.
Methodological Consideration:
Antibody Validation: Ensure specificity via knockout tissue controls or siRNA-mediated TH knockdown .
Conjugation Quality: FITC labeling indices (moles of FITC per antibody molecule) >4 may reduce antigen binding affinity due to steric hindrance . Validate using dot-blot assays comparing labeled vs. unlabeled antibody reactivity .
Optimal dilution depends on antibody affinity, target abundance, and detection system sensitivity.
Validation Step: Perform checkerboard titrations using positive controls (e.g., substantia nigra lysates for WB, midbrain sections for IF) .
Primary Controls:
Tissue-Specific Controls:
FITC labeling index (LI) critically impacts assay specificity and sensitivity:
| Labeling Index (LI) | Binding Affinity (KD) | Non-Specific Staining Risk | Ideal Use Case |
|---|---|---|---|
| 1–3 | <10 nM | Low | Quantitative confocal imaging |
| 4–6 | 10–50 nM | Moderate | High-throughput screening |
| >6 | >50 nM | High | Avoid for precise localization |
Data derived from FITC-antibody characterization studies .
Mitigation Strategy: For multiplex assays pairing TH-FITC with other fluorophores, use LI ≤3 and spectral unmixing algorithms to minimize crosstalk .
Discrepancies often arise from post-transcriptional regulation or antibody cross-reactivity.
Stepwise Analysis:
Technical Validation:
Biological Validation:
Ratiometric Analysis Protocol:
Internal Standard: Co-stain with a spectrally distinct antibody (e.g., Cy5-conjugated NeuN) for normalization .
Image Acquisition:
Use consistent exposure times across samples.
Capture z-stacks to account for tissue thickness variability.
Data Expression:
Calculate FITC:Cy5 ratio to control for section-to-section variability.
Pitfall Avoidance: Ensure linear detection range by plotting signal intensity vs. exposure time .
| Tissue Type | Fixation Artifact Mitigation | Antigen Retrieval Method |
|---|---|---|
| Frozen Sections | Acetone fixation ≤10 min | 0.1% Triton X-100 permeabilization |
| Formalin-Fixed | 24 hr post-fixation in 4% PFA | Citrate buffer (pH 6.0, 95°C, 30 min) |
Validation: Compare TH-FITC signal with tyramide signal amplification (TSA) to confirm epitope accessibility .
Chemical Quenching: Treat sections with 0.3% Sudan Black B (10 min) to suppress lipofuscin autofluorescence .
Cross-Absorption: Preabsorb antibody with adrenal lysate (1 mg/mL, 2 hr) to remove non-specific IgGs .
Critical Parameters:
Lot-to-Lot Consistency: Assess via ELISA against recombinant TH (EC50 shift >2-fold indicates incompatibility) .
Normalization: Include a reference sample (e.g., commercial TH-positive control slides) in each experiment .
Feasibility and Limitations: